Related Content
- Big Molecule WatchMay 3, 2024
FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars
- Big Molecule WatchMay 2, 2024
Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf)
- Big Molecule WatchMay 1, 2024
PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid
- Life Sciences PerspectivesApril 30, 2024
FDA Issues Final Rule on Regulation of Laboratory Developed Tests
- Big Molecule WatchApril 30, 2024
Biosimilar Approval Updates in Europe and China
- Big Molecule WatchApril 29, 2024
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents
- Big Molecule WatchApril 29, 2024
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR
- Big Molecule WatchApril 26, 2024
Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar
- Press ReleaseMay 2, 2024
Mariana Oncology To Be Acquired by Novartis For $1 Billion Upfront, And Up To $750 Million in Milestones
- Press ReleaseApril 29, 2024
Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion
- Press Release29 April 2024
Amid Continued Growth in the United Kingdom, Goodwin Relocates London Office to Iconic Paternoster Square
- Press ReleaseApril 23, 2024
Allurion Technologies Completes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Press ReleaseApril 22, 2024
Sound Bioventures joins £19 Million Financing of Theolytics
- In the PressApril 22, 2024
PowerUp 4 - Omer Tene (Spotify)
- Awards and RankingsApril 18, 2024
Goodwin is Number One in the Q1 2024 League Table Rankings
- Press ReleaseApril 18, 2024
Lumicell’s Novel Optical Imaging Agent Platform LUMISIGHT™ & Direct Visualization System for Detection of Residual Breast Cancer Receives FDA Approval